Efficacy of Replacement and Anti-Platelet Therapies in a Patient with Severe Haemophilia A Undergoing Percutaneous Coronary Stent Implantation
Introduction: Severe haemophilia A is characterized by serious factor VIII deficiency (biological activity <1%) resulting in frequent spontaneous haemorrhage and abnormal bleeding after minor injury, surgery or tooth extraction. Patient and Methods: We report the case of a 58-year-old patient wi...
Main Authors: | Dorina Cultrera, Sergio Cabibbo |
---|---|
Format: | Article |
Language: | English |
Published: |
SMC MEDIA SRL
2022-07-01
|
Series: | European Journal of Case Reports in Internal Medicine |
Subjects: | |
Online Access: | https://www.ejcrim.com/index.php/EJCRIM/article/view/3343 |
Similar Items
-
Real-World Rates of Bleeding, Factor VIII Use, and Quality of Life in Individuals with Severe Haemophilia A Receiving Prophylaxis in a Prospective, Noninterventional Study
by: Gili Kenet, et al.
Published: (2021-12-01) -
Analysis of the correlation between body weight, body composition, and factor VIII recovery in paediatric patients with severe haemophilia A – a single-centre study
by: Katarzyna Koch, et al.
Published: (2023-09-01) -
Therapeutic and routine prophylactic properties of rFactor VIII Fc (efraloctocog alfa, Eloctate®) in hemophilia A
by: Chowdary P, et al.
Published: (2016-09-01) -
Analytical Performance of Different Laboratory Methods for Measuring Susoctocog-Alfa
by: Cristina Novembrino, et al.
Published: (2022-08-01) -
FREQUENCY AND LEVELS OF FACTOR EIGHT INHIBITORS IN KNOWN HAEMOPHILIACS
by: Mumtaz Amir, et al.
Published: (2018-08-01)